Cannabinoid Receptor CB2 Subtype: A Novel Pharmacological Target in Cancer and Neurodegenerative Diseases

Authors

  • Contino M* Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, Italy Author
  • Giampietro R Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, Italy Author

DOI:

https://doi.org/10.23880/oajpr-16000178

Keywords:

Cannabinoid receptor, Neurodegenerative diseases, Cancer

Abstract

CB2 receptor (CB2R) is one of the canonical cannabinoid receptor belonging to endocannabinoid system (ECS). It was cloned for the first time in 1993 from the human leukemia cell line HL-60, and it is part of the Gprotein coupled receptors family (GPCRs), being coupled to a Gi/o protein.

Downloads

Published

2019-06-07

Issue

Vol. 3 No. 2 (2019)

Section

Articles

License

Copyright (c) 2019 Contino M

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

Cannabinoid Receptor CB2 Subtype: A Novel Pharmacological Target in Cancer and Neurodegenerative Diseases. (2019). Open Access Journal of Pharmaceutical Research, 3(2), 1-3. https://doi.org/10.23880/oajpr-16000178